Lymphoma Trial, Recruiting NCT02835911 Sponsor: UNC Lineberger Comprehensive Cancer Center Condition: Lymphoma
Back to Lymphoma

Lymphoma Trial, Recruiting

NCT02835911
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been referred to Kamuzu Central Hospital (KCH) because their doctors suspect they may have lymphoma.
  • People who are older than 5 years of age, or children aged 5 years and under only if lymphoma has already been confirmed by laboratory testing.
  • People who have not previously been diagnosed with any cancer and are not currently receiving any cancer treatment.
  • People who live within 200 kilometres of Kamuzu Central Hospital.
  • People who are able to follow the study procedures for the full length of the study, with the help of a parent or guardian if needed.
  • People (or their parent or guardian) who are able to understand and sign a consent form written in English or Chichewa.

Who may not be able to join:

  • People who do not meet all of the requirements listed above are not eligible to join.

Additional note:

  • Participants may choose to take part in the study but decline to have their lymphoma tissue samples used for detailed genetic analysis — this is permitted (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
UNC Lineberger Comprehensive Cancer Center
Registry
ClinicalTrials.gov
Start date
1 November 2012
Est. completion
31 January 2030

Where this trial is recruiting

Malawi

Primary endpoints

Number of patients with suspected lymphoma

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov